Arimagenomics
1 known investors
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with structural information to detect cancer-driving mutations and rearrangements. The company delivers clinical testing services (Aventa) for oncologists and partners with biopharma teams to identify therapeutic biomarkers.
BiotechDigital HealthMedical Devices